Rankings

Market Cap
Revenue
Operating Income
CapEx
Total Assets
Net Assets
Cash on Hand

Sectors

Technology
Healthcare
Financial Services
Consumer Cyclical
Communication Services
Industrials
Consumer Defensive
Energy
Basic Materials
Real Estate
Utilities

Pages

Home
Earnings Calendar
All Sectors
Terms
Privacy

© 2026 Market Cap Arena. All rights reserved.v1.2.31

ACET Q1 2016 Earnings — Adicet Bio, Inc. Revenue & Financial Results | Market Cap Arena

ACETAdicet Bio, Inc.

$69M

Q1 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$158M

Gross Profit

$38M24.2% margin

Operating Income

$16M10.4% margin

Net Income

$10M6.6% margin

EPS (Diluted)

$6.40

QoQ Revenue Growth

+19.9%

Cash Flow

Operating Cash Flow

$755,000

Free Cash Flow

$602,000

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$545M

Total Liabilities

$246M

Stockholders' Equity

$299M

Cash & Equivalents

$53M

Revenue Segments

Human Health

$59M37%

Performance Chemicals

$53M34%

Pharmaceutical Ingredients

$46M29%

← FY 2016 All Quarters Q2 2016 →